Table 3.
Activity of 2–4 against Hep3B and Hep3B-VIN
GI50 (µM) | |||
---|---|---|---|
Hep3B | Hep3B-VIN | Hep3B/Hep3B-VIN | |
2 | 47.57 | 1.57 | 30 |
3 | 7.31 | 0.35 | 21 |
4 | 6.09 | 0.72 | 8.5 |
paclitaxel | 0.0004 | 16.17 | - |
vincristine | 0.0029 | 6.86 | - |
Activity of 2–4 against Hep3B and Hep3B-VIN
GI50 (µM) | |||
---|---|---|---|
Hep3B | Hep3B-VIN | Hep3B/Hep3B-VIN | |
2 | 47.57 | 1.57 | 30 |
3 | 7.31 | 0.35 | 21 |
4 | 6.09 | 0.72 | 8.5 |
paclitaxel | 0.0004 | 16.17 | - |
vincristine | 0.0029 | 6.86 | - |